Blueprint Medicines is a global precision therapy company inventing life-changing therapies for people with cancer and blood disorders. Applying an approach that is both precise and agile, our medicines selectively target genetic drivers, with the goal of staying one step ahead of disease.
Products, services, technology
Our pipeline of approved and investigational therapies represent our focus to rapidly and reproducibly translate our scientific innovation into a broad pipeline of therapies aimed at addressing difficult-to-treat cancers and blood disorders.
We believe when we work together, the impact of our collective efforts can make a profound difference for patients, our employees and the communities where we live and work. We’re grounded in integrity, we lead with our core values and we’re inspired to make the world a better place.
At Blueprint Medicines, we're proud of how we work together to navigate uncharted territory in kinase medicines, to help patients with genomically defined cancers and rare diseases.
Our culture of transparency, curiosity and diversity empowers us to draw upon various backgrounds and perspectives to build a conscientious team dynamic. Each day, our teams commit to approach one another with respect and trust: a simple promise that fosters an inclusive and collaborative spirit.